[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350575-105":59,"doc-detail-350575-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","plateletneutrophil-cooperation-in-cancer-mechanisms-of-metastatic-niche-formation-and-implications-for-prognostic-stratification-and-therapy","Platelet–neutrophil cooperation in cancer: mechanisms of metastatic niche formation and implications for prognostic stratification and therapy","","Metastasis remains the leading cause of cancer-related mortality, driven by ongoing interactions between malignant cells and the tumor microenvironment. Platelets and neutrophils emerge as key regulators of metastatic potential, acting through coordinated platelet–neutrophil aggregates and related mixed-cell complexes to promote immune escape, vascular adaptation, and preparation of distant sites. This review unifies mechanisms involving circulation survival, immune evasion, adhesion, egress, and tissue targeting via signaling factors, cell adhesion, NET–inflammatory responses linked to coagulation, and persistent effects from extracellular vesicles and metabolism. It also highlights clinical translation gaps, emphasizing biomarker models combining platelet measures with NLR.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/plateletneutrophil-cooperation-in-cancer-mechanisms-of-metastatic-niche-formation-and-implications-for-prognostic-stratification-and-therapy/350575/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/plateletneutrophil-cooperation-in-cancer-mechanisms-of-metastatic-niche-formation-and-implications-for-prognostic-stratification-and-therapy/350575.png","ImageObject",300,407,{"name":92,"@type":93},"Blitz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do platelet–neutrophil aggregates contribute to metastasis?","Question",{"text":112,"@type":113},"They act as coordinated regulators that promote immune escape, vascular adaptation, and preparation of distant metastatic sites by linking multiple steps of tumor spreading.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which biological mechanisms are highlighted in the review?",{"text":117,"@type":113},"Mechanisms include soluble signaling factors, cell-cell adhesion, NET–inflammatory responses connected to coagulation, and longer-lasting effects from extracellular vesicles and metabolism.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is clinical translation of platelet–neutrophil targeting still challenging?",{"text":121,"@type":113},"Platelet and neutrophil blood-count markers are not consistently used across cancer types, the timing of neutrophil functional state changes is unclear, and therapies must balance antimetastatic benefit with risks like bleeding and impaired host defense.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350575,1790923184,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Cellular Oncology (2026) 49:95  \n[https://doi.org/10.1007/s13402-026-01](https://doi.org/10.1007/s13402-026-01)178-6  \nREVIEW  \nPlatelet–neutrophil cooperation in cancer: mechanisms of metastatic niche formation and implications for prognostic stratification and therapy  \nNa Yang1 · Jiahui Gong2,3 · Chang Ge4 · Gujie Wu5 · Guopeng Chen6,7,8 · Jingjing Li1 · Weiwei Tang1 · Bin Wang9 · Xisha Li10 · Lee Sheung3 · Ziyue Wang11 · Jiangchao Li1  \nReceived: 4 September 2025 / Accepted: 7 February 2026 © The Author(s) 2026  \nAbstract  \nMetastasis remains the leading cause of cancer-related mortality and arises from ongoing interactions between malignant cells and their surrounding microenvironment. Among host factors, platelets and neutrophils have emerged as key regulators of metastatic potential. Growing evidence indicates that their coordinated activity—particularly through platelet–neutrophil aggregates（PNAs） and related mixed-cell complexes—forms an important but underrecognized pathway that promotes immune escape, vascular adaptation, and preparation of distant metastatic sites. This combination alters many critical steps in the spreading process. It includes survival within the circulation, evading the immune response, adhesion to the vessel wall and egress, and shifting target tissues. These are the result of collaborative mechanisms such as the use of soluble signaling factors, cell-cell adhesion, the NET-inflammatory response linked to coagulation, and the more persistent changes conferred by EVs and metabolism. Despite substantial progress in defining these mechanisms, important challenges limit clinical translation. Blood count–based platelet and neutrophil markers are not consistently used to assess metastatic risk across cancer types; the factors that control when and how neutrophils change functional states within tumors remain unclear; and therapeutic strategies that target platelet–neutrophil cooperation must carefully balance antimetastatic efficacy with risks such as bleeding and weakened host defense. In this review, we integrate current evidence on platelet–neutrophil–tumor interactions into a unified framework that connects biological mechanisms with clinically measurable indicators and therapeutic entry points. We examine emerging approaches to reduce metastasis supported by platelet–neutrophil interactions and NET-associated processes, consider how these strategies may complement existing cancer treatments, and emphasize the potential of combined biomarker models—such as integrating platelet measures with the neutrophil-to-lymphocyte ratio（NLR）—to improve prognostic assessment and guide future clinical validation.  \nKeywords Platelet–neutrophil aggregates(pnas) · Metastasis · Immunothrombosis · Neutrophil extracellular traps(nets) · Prognostic biomarkers · Neutrophil-to-lymphocyte ratio (NLR)  \n1 Introduction  \nPlatelets are small cell fragments released from megakaryocytes. They are best known for stopping bleeding, but growing evidence shows they also help shape immune responsesand support tissue repair [1]. In healthy blood vessels, endothelial nitric oxide (NO) and prostacyclin help keep platelets  \ninactive [2, 3] . When a vessel is injured, platelets activate rapidly through surface receptors such as glycoprotein Ib/ IX/V, integrin αIIbβ3 (GPIIb/IIIa), and P-selectin, which enables adhesion, recruitment, and aggregation to form ahemostatic plug, along with the release of granule-derived mediators including CXCL4 (also known as platelet factor 4, PF4), stromal cell–derived factor 1 (SDF-1; also known  \nNa Yang, Jiahui Gong, Chang Ge, and Gujie Wu contributed equally to this work.  \nExtended author information available on the last page of the article  \nas CXCL12), CD40 ligand, and thromboxane A2 (TXA2) . Beyond releasing soluble factors, platelets carry a selected set of megakaryocyte-derived RNAs (mRNAs, miRNAs, lncRNAs, and circRNAs) that can be transferred to other cells and influence gene expression an","cbCaigbFTERFpzdD","https://ap.wps.com/l/cbCaigbFTERFpzdD","pdf",2849012,35,"English","# Abstract\n# Keywords\n# 1 Introduction","[{\"question\":\"How do platelet–neutrophil aggregates contribute to metastasis?\",\"answer\":\"They act as coordinated regulators that promote immune escape, vascular adaptation, and preparation of distant metastatic sites by linking multiple steps of tumor spreading.\"},{\"question\":\"Which biological mechanisms are highlighted in the review?\",\"answer\":\"Mechanisms include soluble signaling factors, cell-cell adhesion, NET–inflammatory responses connected to coagulation, and longer-lasting effects from extracellular vesicles and metabolism.\"},{\"question\":\"Why is clinical translation of platelet–neutrophil targeting still challenging?\",\"answer\":\"Platelet and neutrophil blood-count markers are not consistently used across cancer types, the timing of neutrophil functional state changes is unclear, and therapies must balance antimetastatic benefit with risks like bleeding and impaired host defense.\"}]","Platelet–neutrophil cooperation in cancer: mechanisms of metastatic niche formation and implications for prognostic stratification and therapy | PDF",1790089674,88,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4eb5e6a213f4556adb4c27a091e2a67.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d036318da59f055895373e6e0d6617c.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb4a6ded04e147ae2470a9c6765c0b5a.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/217fa9919a1d48699df389b2c5ba287b.webp",980,1301]